placeholder image
D. P. Bender All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. 
    Cancer. 2024
    • Contact
    full name
  • D. P. Bender
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration